Certificate under Regulation 74(5) of the SEBI (DP) Regulations for the Q ended 30th September 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sandu Pharmaceuticals has submitted a compliance certificate under SEBI Regulation 74(5) to BSE, CDSL, and NSDL for the quarter ended 30 September 2025. The certificate was issued by MUFG Intime India Pvt. Ltd. (formerly Link Intime), the company's Registrar and Share Transfer Agent. It confirms that all share certificates received for dematerialisation during the quarter were duly verified, the corresponding securities were listed on the stock exchange, and the old certificates were mutilated and cancelled. The depository's name has been substituted as the registered owner in the company's register of members within the prescribed timelines.
This is a routine quarterly compliance filing and carries no material impact on the business, financials, or share price. It simply certifies that share dematerialisation activity was processed properly during the quarter.